REATA PHARMACEUTICALS INC's ticker is RETA and the CUSIP is 75615P103. A total of 161 filers reported holding REATA PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is 1.49 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $46,055,332 | +55.9% | 451,700 | +39.0% | 0.23% | +43.5% |
| Q1 2023 | $29,549,000 | +134.3% | 325,000 | -2.1% | 0.16% | +114.7% |
| Q4 2022 | $12,612,680 | -17.7% | 332,000 | +342.7% | 0.08% | -27.2% |
| Q4 2019 | $15,332,000 | +4.9% | 75,000 | -58.8% | 0.10% | -6.4% |
| Q3 2019 | $14,618,000 | -80.6% | 182,060 | -77.2% | 0.11% | -77.6% |
| Q2 2019 | $75,480,000 | +17.7% | 800,000 | +6.7% | 0.49% | +1.9% |
| Q1 2019 | $64,103,000 | +63.2% | 750,000 | +7.1% | 0.48% | +67.4% |
| Q4 2018 | $39,270,000 | -28.7% | 700,000 | +3.9% | 0.29% | -11.4% |
| Q3 2018 | $55,065,000 | – | 673,500 | – | 0.32% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CPMG Inc | 2,896,901 | $295,368,026 | 59.26% |
| Ally Bridge Group (NY) LLC | 105,558 | $10,762,694 | 13.04% |
| First Light Asset Management, LLC | 1,432,208 | $146,027,928 | 11.44% |
| Boxer Capital, LLC | 1,430,004 | $145,803 | 6.76% |
| MPM BioImpact LLC | 234,478 | $23,907,377 | 4.81% |
| Tri Locum Partners LP | 96,274 | $9,816,097 | 3.65% |
| Altium Capital Management LP | 41,485 | $4,229,811 | 3.20% |
| Ghost Tree Capital, LLC | 85,000 | $8,666,600 | 2.86% |
| KRS Capital Management, LLC | 27,941 | $2,848,864 | 2.85% |
| Sofinnova Investments, Inc. | 322,471 | $32,879,143 | 2.15% |